[1]
S. M. Adamu, O. S. Oyewole, and U. F. Kabir, “Efficacy and safety of combination of poly-ADP-ribose polymerase inhibitor (PARPi) and chemotherapy compared with chemotherapy alone in treatment of recurrent ovarian carcinoma: a systematic review”., Niger Med J, vol. 65, no. 1, pp. 1–15, Apr. 2024.